FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      
1. Name and Address of Reporting Person * BREEN EDWARD D 2. Issuer Name and Ticker or Trading Symbol DuPont de Nemours, Inc. [ DD ] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable)__X__ Director                    _____ 10% Owner
__X__ Officer (give title below)    _____ Other (specify below)
Chief Executive Officer
(Last)         (First)         (Middle)
CHESTNUT RUN PLAZA 730, 974 CENTRE ROAD
3. Date of Earliest Transaction (MM/DD/YYYY)
8/3/2020
(Street)
WILMINGTON, DE 19805
(City)       (State)       (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)
 
6. Individual or Joint/Group Filing (Check Applicable Line) _X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock  8/3/2020    A    37384 (1) A $53.5 (2) 206997.295 (3) D   
Common Stock                 9660  I  GRAT 
Common Stock                 27942  I  GRAT 
Common Stock                 71532  I  GRAT 

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Options (Right to Buy) NQOs  $53.5 (4) 8/3/2020    A     226245 (5)     8/3/2021 (6) 8/2/2030  Common Stock  226245  $0  226245  D   
Deferred Stock Units   (7)                  (8)  (8) Common Stock  261.4771 (9)   261.4771 (9) D   

Explanation of Responses:
(1)  This represents the RSU component of Mr. Breen's regular annual LTI award for 2020 which would have otherwise been made on February 19, 2020, with other management grants, but was delayed due to Mr. Breen's change in role from Executive Chairman to Executive Chairman and CEO; the board approved Mr. Breen's regular annual grant for 2020 at a meeting on August 3.
(2)  Represents the closing value of DuPont common stock on the date of the management grants on February 19, 2020, which was greater than the grant date fair value. See footnote (1).
(3)  Includes acquisition of shares pursuant to dividend reinvestment; 18, 915 shares of direct ownership reclassified from indirect holdings in a GRAT; also 71,532 shares reclassified from direct to indirect holdings in a GRAT.
(4)  Represents the closing value of DuPont common stock on the date of the management grants on February 19, 2020, which was greater than the grant date fair value. See footnote (5).
(5)  This represents the stock options component of Mr. Breen's regular annual LTI award for 2020 which would have otherwise been made on February 19, 2020, with other management grants, but was delayed due to Mr. Breen's change in role from Executive Chairman to Executive Chairman and CEO; the board approved Mr. Breen's regular annual grant for 2020 at a meeting on August 3.
(6)  Options become exercisable in three substantially equal installments beginning on the first anniversary of the grant; option shares may be used to satisfy withholding taxes.
(7)  Each unit represents the right to receive one share of DuPont common stock.
(8)  Units are payable in shares following termination of the reporting person's employment with DuPont. The reporting person may transfer his units into an alternative investment account at any time.
(9)  Includes acquisition of shares pursuant to dividend reinvestment; this number is also reflective of the reverse stock split on June 1, 2019.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
BREEN EDWARD D
CHESTNUT RUN PLAZA 730
974 CENTRE ROAD
WILMINGTON, DE 19805
X
Chief Executive Officer

Signatures
Peter Hennessey by Power of Attorney 8/5/2020
**Signature of Reporting Person Date
DuPont de Nemours (NYSE:DD)
Historical Stock Chart
From Dec 2020 to Jan 2021 Click Here for more DuPont de Nemours Charts.
DuPont de Nemours (NYSE:DD)
Historical Stock Chart
From Jan 2020 to Jan 2021 Click Here for more DuPont de Nemours Charts.